BlockQuarry Corp. Enhances Healthcare Processes and Strategic Acquisitions to Accelerate AI-Driven Innovation

HOUSTON, Oct. 08, 2024 (GLOBE NEWSWIRE) — via IBN – BlockQuarry Corp. (OTC: BLQC), a pioneer in AI-driven healthcare solutions, today announced the acquisition of Telecare Home Health LLC and Paradigm Home Health LLC, two established home healthcare companies. The move strengthens BlockQuarry’s growth in the healthcare sector, expanding its ability to deliver artificial intelligence (AI)-based solutions and improve patient outcomes through clinical trials and global analytics.

Strategic Acquisitions Increase Growth

The acquisition of Telecare Home Health and Paradigm Home Health significantly expands BlockQuarry’s patient base and access to valuable data, creating synergies that will drive operational growth and enhance the company’s offerings. With both companies making more than $1 million a year, BlockQuarry is poised to continue growing in the healthcare industry.

“These acquisitions are key steps in our long-term vision to strengthen BlockQuarry’s position as an innovator in healthcare solutions. By combining our expertise in AI with the capabilities of Telecare and Paradigm, we are accelerating the development of clinical trials and reforming patient care,” said Alonzo Pierce, chairman and president of BlockQuarry Corp.

Using AI to Transform Healthcare

BlockQuarry’s findings open up new opportunities to use AI and health data for better and more efficient efforts. By using AI to analyze patient data and improve test design, BlockQuarry will:

• Promote Data-Driven Insights: Use real-world evidence (RWE) to drive smarter clinical trial decisions, optimizing outcomes.

• Expand Patient Registration: Get a large, diverse group of participants for the experiment, and improve the representativeness of the experiment.

• Strengthen the Work: Oversee clinical trial processes and potential breakthroughs, based on the combined capabilities of the acquired companies.

Stands for Growth and Innovation

This acquisition provides a solid foundation for future growth, allowing BlockQuarry to expand its service offerings and explore additional opportunities in the healthcare data analytics space. As a publicly traded company, BlockQuarry is committed to using its resources to expand its operations and develop leading AI solutions that contribute to better patient outcomes.

“Our integration of AI into healthcare is not only increasing the efficiency of clinical trials but also helping to address critical gaps in patient care. This is an important time for BlockQuarry as we move forward in this new chapter,” added Pierce.

The story continues

Effective Management of Better Patient Outcomes

BlockQuarry’s focus on real-world evidence and health equity ensures that clinical trials reach a diverse population, resulting in results that can be interpreted across multiple patient groups. By improving the speed and efficiency of clinical trials, BlockQuarry’s innovations will help develop new treatments that address unmet medical needs.

Looking Ahead

As BlockQuarry continues to strengthen its position in the healthcare sector, the company is well positioned to become a leader in AI-driven healthcare solutions. With a focus on technology growth and innovation, BlockQuarry is changing the way healthcare data is processed and used to drive patient outcomes.

The opinion of the company BlockQuarry Corp.
BlockQuarry Corp. (BLQC) stands at the forefront of innovation in the US energy and infrastructure sectors, passionately committed to advancing carbon-negative industrial energy worldwide. A specialist provider of green, sustainable and reliable energy solutions, BlockQuarry serves industries with energy requirements, including data centers, manufacturing, cryptocurrency mining, and AI.

For more information, please contact us at info@blockquarry.io.

Forward-Looking Comments
This article contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those expressed or implied in these statements.

Corporate Communications:
IBN
Los Angeles, California
www.InvestorBrandNetwork.com
Office 310.299.1717
Editor@InvestorBrandNetwork.com